BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 885 filers reported holding BAXTER INTL INC in Q3 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $100,032,998 | -51.6% | 2,650,582 | -41.6% | 0.01% | -47.1% |
| Q2 2023 | $206,652,339 | -52.6% | 4,535,827 | -57.8% | 0.02% | -15.0% |
| Q1 2023 | $436,409,308 | +588.5% | 10,759,598 | +765.3% | 0.02% | +233.3% |
| Q4 2022 | $63,382,405 | -50.1% | 1,243,523 | -47.2% | 0.01% | -53.8% |
| Q3 2022 | $126,896,000 | +14.7% | 2,356,034 | +36.8% | 0.01% | +18.2% |
| Q2 2022 | $110,612,000 | +67.2% | 1,722,127 | +101.9% | 0.01% | +120.0% |
| Q1 2022 | $66,142,000 | +10.3% | 853,002 | +22.1% | 0.01% | +25.0% |
| Q4 2021 | $59,966,000 | -0.3% | 698,574 | -6.6% | 0.00% | -20.0% |
| Q3 2021 | $60,153,000 | +67.5% | 747,877 | +67.6% | 0.01% | +66.7% |
| Q2 2021 | $35,912,000 | -45.9% | 446,125 | -43.3% | 0.00% | -50.0% |
| Q1 2021 | $66,370,000 | -15.9% | 786,941 | -20.0% | 0.01% | -14.3% |
| Q4 2020 | $78,933,000 | -76.0% | 983,720 | -76.0% | 0.01% | -78.8% |
| Q3 2020 | $329,279,000 | -69.6% | 4,094,489 | -67.4% | 0.03% | -72.3% |
| Q2 2020 | $1,082,357,000 | -4.0% | 12,570,932 | -9.5% | 0.12% | -23.7% |
| Q1 2020 | $1,127,503,000 | -0.0% | 13,887,218 | +2.9% | 0.16% | +25.8% |
| Q4 2019 | $1,128,047,000 | -32.3% | 13,490,158 | -29.1% | 0.12% | -38.0% |
| Q3 2019 | $1,665,028,000 | +9.2% | 19,035,422 | +2.3% | 0.20% | +12.4% |
| Q2 2019 | $1,524,062,000 | -8.9% | 18,608,826 | -9.5% | 0.18% | -11.0% |
| Q1 2019 | $1,672,778,000 | +5.6% | 20,572,838 | -14.5% | 0.20% | -7.8% |
| Q4 2018 | $1,583,667,000 | -30.0% | 24,060,579 | -18.0% | 0.22% | -14.9% |
| Q3 2018 | $2,263,057,000 | +7.0% | 29,356,040 | +2.5% | 0.26% | +4.9% |
| Q2 2018 | $2,114,558,000 | +42.6% | 28,637,027 | +25.6% | 0.24% | +38.1% |
| Q1 2018 | $1,482,347,000 | +137.7% | 22,791,307 | +136.2% | 0.18% | +141.1% |
| Q4 2017 | $623,696,000 | +28.2% | 9,648,759 | +24.5% | 0.07% | +23.7% |
| Q3 2017 | $486,374,000 | +18.9% | 7,750,972 | +14.7% | 0.06% | +15.7% |
| Q2 2017 | $409,082,000 | +144.6% | 6,757,214 | +109.5% | 0.05% | +142.9% |
| Q1 2017 | $167,273,000 | +114.1% | 3,225,482 | +83.1% | 0.02% | +110.0% |
| Q4 2016 | $78,129,000 | -55.1% | 1,762,039 | -51.8% | 0.01% | -56.5% |
| Q3 2016 | $174,155,000 | +114.2% | 3,658,703 | +103.5% | 0.02% | +109.1% |
| Q2 2016 | $81,294,000 | -7.1% | 1,797,728 | -15.6% | 0.01% | -8.3% |
| Q1 2016 | $87,549,000 | +51.1% | 2,131,159 | +40.3% | 0.01% | +50.0% |
| Q4 2015 | $57,935,000 | -52.6% | 1,518,597 | -59.2% | 0.01% | -52.9% |
| Q3 2015 | $122,353,000 | -54.7% | 3,724,615 | -3.6% | 0.02% | -51.4% |
| Q2 2015 | $270,126,000 | -9.0% | 3,862,797 | -10.9% | 0.04% | -7.9% |
| Q1 2015 | $296,917,000 | -0.2% | 4,334,564 | +6.7% | 0.04% | -2.6% |
| Q4 2014 | $297,624,000 | -8.1% | 4,060,913 | -10.0% | 0.04% | -11.4% |
| Q3 2014 | $324,009,000 | -12.2% | 4,514,552 | -11.6% | 0.04% | -10.2% |
| Q2 2014 | $369,219,000 | -6.6% | 5,106,755 | -4.9% | 0.05% | -10.9% |
| Q1 2014 | $395,117,000 | +11.2% | 5,369,907 | +5.1% | 0.06% | +10.0% |
| Q4 2013 | $355,210,000 | -3.0% | 5,107,263 | -8.4% | 0.05% | -10.7% |
| Q3 2013 | $366,181,000 | -10.4% | 5,574,361 | -5.5% | 0.06% | -16.4% |
| Q2 2013 | $408,642,000 | – | 5,899,248 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |